SABS logo

SAB Biotherapeutics (SABS) Accounts Receivable

Annual Accounts Receivable

$0.00
-$5.56 M-100.00%

31 December 2023

SABS Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Receivable

N/A

30 September 2024

SABS Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SABS Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-100.0%-
3 y3 years-100.0%-
5 y5 years--

SABS Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-100.0%
5 y5 years-100.0%
alltimeall time-100.0%

SAB Biotherapeutics Accounts Receivable History

DateAnnualQuarterly
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
Sept 2023
-
$0.00(-100.0%)
June 2023
-
$364.10 K(-52.3%)
Mar 2023
-
$763.10 K(-86.3%)
Dec 2022
$5.56 M
$5.56 M(-57.1%)
Sept 2022
-
$12.94 M(+34.6%)
DateAnnualQuarterly
June 2022
-
$9.61 M(-18.4%)
Mar 2022
-
$11.79 M(+47.1%)
Dec 2021
$8.01 M(-61.1%)
$8.01 M(-53.2%)
June 2021
-
$17.11 M(-16.8%)
Dec 2020
$20.57 M(+629.8%)
$20.57 M
Dec 2019
$2.82 M
-

FAQ

  • What is SAB Biotherapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for SAB Biotherapeutics?
  • What is SAB Biotherapeutics annual accounts receivable year-on-year change?
  • What is the all time high quarterly accounts receivable for SAB Biotherapeutics?

What is SAB Biotherapeutics annual accounts receivable?

The current annual accounts receivable of SABS is $0.00

What is the all time high annual accounts receivable for SAB Biotherapeutics?

SAB Biotherapeutics all-time high annual accounts receivable is $20.57 M

What is SAB Biotherapeutics annual accounts receivable year-on-year change?

Over the past year, SABS annual accounts receivable has changed by -$5.56 M (-100.00%)

What is the all time high quarterly accounts receivable for SAB Biotherapeutics?

SAB Biotherapeutics all-time high quarterly accounts receivable is $20.57 M